Characterization of Spirometric Response to Standard-of-care Treatment in Lung Allograft Recipients With Bronchiolitis Obliterans and the Utility of Spirometric Criteria for Rescue Therapy: Implications for the Design of Risk-stratified Clinical Tria

Patients with BOS have a widely variable response to SOC therapy. Our findings support the use of FEV 1 rate of decline to assess response to SOC therapy and to ensure appropriate assignment of participants with refractory BOS to rescue therapy treatment cohorts.

Authors

Institutions

Publication Details

Journal
Transplantation
Published
2025-09-24
DOI
https://doi.org/10.1097/tp.0000000000005515
Primary Topic
Transplantation: Methods and Outcomes
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Characterization of Spirometric Response to Standard-of-care Treatment in Lung Allograft Recipients With Bronchiolitis Obliterans and the Utility of Spirometric Criteria for Rescue Therapy: Implications for the Design of Risk-stratified Clinical Tria

Mrunal Patel, Shambhu Aryal, Keith Berman, Howard J. Huang et al.
Transplantation
Transplantation: Methods and Outcomes
article

Characterization of Spirometric Response to Standard-of-care Treatment in Lung Allograft Recipients With Bronchiolitis Obliterans and the Utility of Spirometric Criteria for Rescue Therapy: Implications for the Design of Risk-stratified Clinical Tria

Mrunal Patel, Shambhu Aryal, Keith Berman, Howard J. Huang, Nicole De Simone, John M. Reynolds, Hilary J. Goldberg, Elizabeth A. Lendermon, Keith Wille, Jeffrey J. Atkinson, Rajat Walia, Amena Usmani, George J. Despotis, Selim M. Arcasoy, Gordon Yung, Andrew Atkinson, Brian C. Keller, Chadi A. Hage, Mary Clare Derfler, Derek E. Byers, Jagadish Patil, А. В. Прокудин, Francis Cordova, David R. Nunley, John E. McCarthy, Julia Klesney‐Tait, Suresh Vedantham, Paul K. Commean, Kevin M. Chan, Ramsey R. Hachem, Reda E. Girgis, Andrés Peláez, Chetan Naik, M. Baz, Matthew R. Morrell, Amir Emtazoo
article en

Abstract

Patients with BOS have a widely variable response to SOC therapy. Our findings support the use of FEV 1 rate of decline to assess response to SOC therapy and to ensure appropriate assignment of participants with refractory BOS to rescue therapy treatment cohorts.

TransplantationVol. 110(2)
University of Iowa (US), Brigham and Women's Hospital (US), University of Minnesota (US), University of Miami (US), Spectrum Health (US), University of San Diego (US), University of Pittsburgh (US), Duke University (US), Washington University in St. Louis (US), University of Utah (US), University of Michigan (US), Inova Fairfax Hospital (US), Carter BloodCare (US), Jacksonville College (US), Baylor University Medical Center (US), Dignity Health (US), University of Alabama at Birmingham (US), University of Florida (US), University of California San Diego (US), Massachusetts General Hospital (US), Institut National de la Transfusion Sanguine (FR), Mallinckrodt (United States) (US), Methodist Hospital (US), Nova Medical (United States) (US), Michigan Medicine (US), University of Pittsburgh Medical Center (US), Sierra Engineering (United States) (US), Duke University Hospital (US), The Ohio State University (US), Indiana University – Purdue University Indianapolis (US), Columbia University (US), Temple University (US)
Openalex Percentile: Top 57%
Transplantation: Methods and Outcomes
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.